Sana Biotechnology, Inc.
SANA
$1.76
-$0.01-0.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -49.07M | -59.92M | -50.29M | -107.48M | -88.12M |
| Total Depreciation and Amortization | 3.80M | 4.06M | 3.90M | 3.75M | 4.25M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.17M | 4.39M | -14.49M | 45.56M | 21.66M |
| Change in Net Operating Assets | 4.27M | -344.00K | 2.35M | -7.46M | 10.24M |
| Cash from Operations | -47.16M | -51.82M | -58.54M | -65.63M | -51.96M |
| Capital Expenditure | -436.00K | -4.09M | -13.06M | -15.85M | -14.05M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.52M | 45.87M | 18.87M | -61.38M | 29.36M |
| Cash from Investing | 47.09M | 41.78M | 5.82M | -77.23M | 15.31M |
| Total Debt Issued | -56.00K | 172.00K | 7.63M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 699.00K | 1.91M | 3.00M | 186.40M | 1.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 643.00K | 2.08M | 10.63M | 186.40M | 1.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 570.00K | -7.96M | -42.10M | 43.54M | -34.93M |